From next-generation medications to groundbreaking gene therapies and nonsurgical procedures, explore the pipeline of treatments currently being tested for oHCM.

CYNTHIA Burstein Waldman of Los Angeles got tired of feeling she knew more than her doctors did about her hereditary heart condition, hypertrophic cardiomyopathy; tired of worrying that a provider ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Michelle M.

Peripartum cardiomyopathy is a form of acute and sometimes severe cardiac degeneration that leads to clinical heart failure during pregnancy or in the early postpartum period. The disorder is ...

Researchers conducted a retrospective cohort study (2014-2024) involving 67 children aged 0-3 years with heart failure due to dilated cardiomyopathy (mean age at diagnosis, 0.46 years) to assess ...

Two brothers underwent successful life-saving heart transplants 11 years apart after both were diagnosed with advanced ...

Cardiomyopathy is a disease that affects the heart muscle (known as the myocardium). There are different types of cardiomyopathy. Each of these cause damage to the heart muscle, such as enlarging it ...

Postpartum cardiomyopathy is a type of heart failure that weakens your heart one month before or up to five months after your delivery. Because your heart problems happen around childbirth, it's also ...

In a medical milestone, two brothers underwent life-saving heart transplants due to advanced Dilated Cardiomyopathy (DCM).

Hypertrophic cardiomyopathy (HCM) is a progressive heart disease with four stages. At each stage, HCM has a greater impact on the heart’s structure and function. In the earliest stage, a person will ...

There’s no cure for obstructive hypertrophic cardiomyopathy (oHCM) — treatments focus on symptom management and preventing complications. But the landscape is changing, and more cutting-edge therapies ...